Competitive Analysis of Pharmaceutical Secondary Packaging Market

Key Players

Competitive Landscape

Commercial supply across pharmaceutical secondary packaging balances multi-mill paperboard carton producers against specialized healthcare label and tray converters. Integrated board groups supply virgin and recycled cartonboard along with high-volume folding cartons for oral solid tablets. Specialty healthcare converters focus on multi-page booklet labels and child-resistant wallet packs as well as sterilization-ready RFID vial tags whilst machinery-linked groups offer complete cartoning lines. Because a single unreadable barcode can stop a batch release, quality directors select suppliers based on ISO 15378 compliance and inline camera verification.

Healthcare packaging converters are currently focusing on replacing plastic blister trays inside injectable drug cartons and simplifying unit-level EPCIS data checks. Instead of shipping separate cartons and folded paper leaflets that slow down contract filling lines, suppliers now pre-assemble carton-and-leaflet units and build RFID or NFC inlays into small vial labels. In May 2025, Korber AG deployed STEPLogic Trace EPCIS exception-handling workflows so that drug makers and wholesalers could meet active FDA DSCSA enforcement without holding up warehouse shipments [20]. Following its Berry Global integration, Amcor plc reported full-year fiscal 2026 financial results in August 2026 covering its expanded healthcare folding cartons and medical secondary packaging business across global pharmaceutical accounts [21]. Suppliers that combine wet-strength paperboard trays with verified GS1 serialization are projected to secure long-term biologic supply agreements.

Company developments mapped to drivers, trends and opportunities (2026-2036)

Development	Driver	Trend	Opportunity
August 2026: Faller Packaging acquired Greek pharmaceutical carton and leaflet specialist Paperpack [17].	European drug makers require short-lead regional supply of serialized cartons and outserts.	Dedicated healthcare converters consolidate regional GMP folding-carton and leaflet plants.	Multi-site European converting networks capture pan-regional generic and biologic tenders.
May 2026: Schreiner MediPharm and HERMA demonstrated shielded RFID-Labels on high-speed vial lines [7].	Hospital pharmacies demand automated unit-level tracking on narrow-radius glass vials.	Mechanically shielded RFID chip constructions reduce transponder failure during high-speed labeling.	Turnkey RFID vial labeling systems win high-margin oncology and anesthesia contracts.
May 2026: Korber AG introduced the SPE6-P2 Stickpack Cartoner Line and ALVA inspection system [3].	High-mix low-volume clinical and personalized therapies require rapid packaging line changeovers.	Direct machine integration links primary stickpack filling with secondary P2 cartoning.	Modular inspection and cartoning cells capture CDMO and personalized medicine accounts.
August 2026: Amcor plc completed its first full fiscal year integrating Berry Global healthcare assets [14].	Multinational pharma brands consolidate secondary carton and medical tray vendor lists.	Global converters bundle specialty folding cartons with thermoformed secondary trays and labels.	Single-source healthcare packaging portfolios secure global master supply agreements.

Source: Future Market Insights, Pharmaceutical Secondary Packaging Market Report, 2026-2036.

Recent investments show that leading converters are prioritizing plastic-free injectable trays and automated barcode verification. Suppliers that offer pre-assembled carton-leaflet units along with sterilization-ready RFID labels are expected to win long-term supply contracts across global pharmaceutical plants.

How are key market participants positioned in the pharmaceutical secondary packaging market?

Smurfit Westrock plc and Graphic Packaging International, LLC along with Mayr-Melnhof Karton AG run paperboard mills paired with high-volume pharmaceutical folding-carton plants. Amcor plc combines medical tray converting with specialty healthcare cartons and prescription labels across multiple regions. Meanwhile, CCL Industries Inc. and Schreiner Group GmbH & Co. KG focus on multi-page booklet labels and smart RFID vial tags, whereas Korber Pharma Packaging and Faller Packaging GmbH & Co. KG specialize in complex injectable trays and pre-assembled carton-leaflet packs.

What qualification or purchasing requirements matter most to prospective buyers?

Pharmaceutical packaging directors mandate ISO 15378 Good Manufacturing Practice certification and 100% inline camera verification achieving ISO/IEC 15415 Grade A barcode readability. Biologic drug teams require wet-strength folding boxboard and molded-fiber vial cradles that maintain dimensional locking across 2 degrees Celsius to 8 degrees Celsius cold chains. Procurement officers also prioritize redundant multi-site converting footprints to prevent drug shortages.

Which product or application capabilities distinguish the leading companies?

European healthcare specialists stand out in child-resistant wallet packs and pre-assembled carton-leaflet combinations as well as die-cut paperboard autoinjector trays that replace thermoformed plastic. Global label converters differentiate their lines through autoclave-resistant UHF RFID inlays and multi-layer booklet labels that carry UV and temperature indicators for GLP-1 pens. At the same time, integrated North American and European board groups supply bright virgin and recycled cartonboard built for 500-carton-per-minute laser coding.

How does geographic reach differ among the key market players?

Smurfit Westrock plc and Amcor plc along with CCL Industries Inc. operate pharmaceutical converting plants across the Americas and Europe as well as Asia-Pacific healthcare hubs. Graphic Packaging International, LLC and Mayr-Melnhof Karton AG anchor high-volume cartonboard and folding-carton supply across North America and Europe. By contrast, Faller Packaging GmbH & Co. KG and Korber Pharma Packaging along with Schreiner Group GmbH & Co. KG center their core engineering in Germany and Central Europe whilst supplying biopharma plants in North America and Asia.

Representative Company Overview

Company	Positioning	Verified Development
Smurfit Westrock plc	Global paperboard and pharmaceutical folding-carton group.	Unveiled dedicated clinical pharmaceutical packaging facility in November 2025 [6].
Amcor plc	Multinational healthcare thermoformed tray, label, and carton supplier.	Completed Berry Global integration in FY26 [14] and reported full-year results in August 2026 [21].
Graphic Packaging International, LLC	Integrated virgin and recycled paperboard and healthcare carton producer.	Reported USD 2,188 million Q2 2026 net sales and USD 40 million innovation growth in August 2026 [10].
Mayr-Melnhof Karton AG	European leader in cartonboard and MM Packaging Pharma folding cartons.	Reported full-year 2025 results across board and pharma packaging divisions in March 2026 [19].
CCL Industries Inc.	Global specialty healthcare label, outsert, and RFID converter.	Closed Sleever International acquisition in June 2026 and reported record Q2 results in August 2026 [18].
Korber Pharma Packaging	German specialist in parenteral cardboard trays, cartoners, and EPCIS software.	Launched SPE6-P2 Stickpack cartoner and ALVA inspection at interpack in May 2026 [3].
Schreiner Group GmbH & Co. KG	Developer of Schreiner MediPharm RFID vial labels and GLP-1 pen labels.	Demonstrated shielded RFID-Labels in May 2026 [7] and GLP-1 pen labels in September 2026 [8].
Faller Packaging GmbH & Co. KG	European producer of pharma folding cartons, leaflets, and Combi Packs.	Highlighted 2-in-1 Combi Pack in April 2026 [4] and acquired Paperpack in Greece in August 2026 [17].

Research Methodology

The pharmaceutical secondary packaging market assessment was conducted using a combination of primary research, secondary research, and data triangulation to validate market size, segmentation shares, country-level growth rates, and competitive positioning.